|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 26, 27549-27559, June 25, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
B*









**
¶¶
From the
Departments of
Surgical Oncology, 
Gastrointestinal Medical Oncology, and 
Molecular & Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, the
Visceral and Transplantation Surgery, Inselspital, University of Bern, 3010 Bern, Switzerland, the ¶Department of Molecular Pathology and ||Summer Student Program, The University of Texas-Houston Health Science Center, Houston, Texas 77030, and the **Program in Cancer Biology, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas 77030
Both pro- and antiapoptotic activities of NF-
B transcription factor have been observed; however, less is known about the mechanism by which NF-
B induces apoptosis. To elucidate how NF-
B regulates proapoptotic signaling, we performed functional analyses using wild-type, ikk1-/-, ikk2-/-, rela-/- murine fibroblasts, MDAPanc-28/Puro, MDAPanc-28/I
B
M, and HCT116/p53+/+ and HCT116/p53-/- cells with investigational anticancer agent doxycycline as a superoxide inducer for generating apoptotic stimulus. In this report, we show that doxycycline increased superoxide generation and subsequently activated NF-
B, which in turn up-regulated p53 expression and increased the stability and DNA binding activity of p53. Consequently, NF-
B-dependent p53 activity induced the expression of p53-regulated genes PUMA and p21waf1 as well as apoptosis. Importantly, lack of RelA, IKK, and p53 as well as expression of a dominant negative I
B
(I
B
M) inhibited NF-
B-dependent p53 activation and apoptosis. The doxycycline-induced NF-
B activation was not inhibited in HCT116/p53-/- cells. Our results demonstrate that NF-
B plays an essential role in activation of wild-type p53 tumor suppressor to initiate proapoptotic signaling in response to overgeneration of superoxide. Thus, these findings reveal a mechanism of NF-
B-regulated proapoptotic signaling.
Received for publication, December 9, 2003 , and in revised form, March 11, 2004.
* The work was supported by NCI, National Institutes of Health Grants CA78778-01 and PA-98-029 and by a grant from the Lockton Fund for Pancreatic Cancer Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶¶ To whom correspondence should be addressed: Dept. of Surgical Oncology and Department of Molecular & Cellular Oncology, Unit 107, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030. Tel.: 713-794-1030; Fax: 713-794-4830; E-mail: pjchiao{at}mail.mdanderson.org.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. Lu, K. A. Becker, M. J. Hagen, H. Yan, A. L. Roberts, L. A. Mathews, S. S. Schneider, H. T. Siegelmann, K. J. MacBeth, S. M. Tirrell, et al. Transcriptional Responses to Estrogen and Progesterone in Mammary Gland Identify Networks Regulating p53 Activity Endocrinology, October 1, 2008; 149(10): 4809 - 4820. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Chapoval, A. Al-Garawi, J. M. Lora, I. Strickland, B. Ma, P. J. Lee, R. J. Homer, S. Ghosh, A. J. Coyle, and J. A. Elias Inhibition of NF-{kappa}B Activation Reduces the Tissue Effects of Transgenic IL-13 J. Immunol., November 15, 2007; 179(10): 7030 - 7041. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kawamata, J. Chen, and H. P. Koeffler Suberoylanilide hydroxamic acid (SAHA; vorinostat) suppresses translation of cyclin D1 in mantle cell lymphoma cells Blood, October 1, 2007; 110(7): 2667 - 2673. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Furuya, T. Ozaki, T. Hanamoto, M. Hosoda, S. Hayashi, P. A. Barker, K. Takano, M. Matsumoto, and A. Nakagawara Stabilization of p73 by Nuclear I{kappa}B Kinase-{alpha} Mediates Cisplatin-induced Apoptosis J. Biol. Chem., June 22, 2007; 282(25): 18365 - 18378. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Alvira, A. Abate, G. Yang, P. A. Dennery, and M. Rabinovitch Nuclear Factor-{kappa}B Activation in Neonatal Mouse Lung Protects against Lipopolysaccharide-induced Inflammation Am. J. Respir. Crit. Care Med., April 15, 2007; 175(8): 805 - 815. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Minsavage and J. F. Dillman III Bifunctional Alkylating Agent-Induced p53 and Nonclassical Nuclear Factor {kappa}B Responses and Cell Death Are Altered by Caffeic Acid Phenethyl Ester: A Potential Role for Antioxidant/Electrophilic Response-Element Signaling J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 202 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bonofiglio, S. Aquila, S. Catalano, S. Gabriele, M. Belmonte, E. Middea, H. Qi, C. Morelli, M. Gentile, M. Maggiolini, et al. Peroxisome Proliferator-Activated Receptor-{gamma} Activates p53 Gene Promoter Binding to the Nuclear Factor-{kappa}B Sequence in Human MCF7 Breast Cancer Cells Mol. Endocrinol., December 1, 2006; 20(12): 3083 - 3092. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. O. Baxter, P. J. Came, K. Abell, B. Kedjouar, M. Huth, K. Rajewsky, M. Pasparakis, and C. J. Watson IKK{beta}/2 induces TWEAK and apoptosis in mammary epithelial cells Development, September 1, 2006; 133(17): 3485 - 3494. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Collett and F. C. Campbell Overexpression of p65/RelA potentiates curcumin-induced apoptosis in HCT116 human colon cancer cells Carcinogenesis, June 1, 2006; 27(6): 1285 - 1291. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hu, Z. Han, A. D. Couvillon, R. J. Kaufman, and J. H. Exton Autocrine Tumor Necrosis Factor Alpha Links Endoplasmic Reticulum Stress to the Membrane Death Receptor Pathway through IRE1{alpha}-Mediated NF-{kappa}B Activation and Down-Regulation of TRAF2 Expression Mol. Cell. Biol., April 15, 2006; 26(8): 3071 - 3084. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Liu and A. B. Malik NF-{kappa}B activation as a pathological mechanism of septic shock and inflammation Am J Physiol Lung Cell Mol Physiol, April 1, 2006; 290(4): L622 - L645. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sun, D. E. C. Wilkins, M. R. Anver, T. J. Sayers, A. Panoskaltsis-Mortari, B. R. Blazar, L. A. Welniak, and W. J. Murphy Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicity Blood, November 1, 2005; 106(9): 3293 - 3299. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shim and T. E. Eling Protein Kinase C-dependent Regulation of NAG-1/Placental Bone Morphogenic Protein/MIC-1 Expression in LNCaP Prostate Carcinoma Cells J. Biol. Chem., May 13, 2005; 280(19): 18636 - 18642. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Li, J. Niu, T. Uwagawa, B. Peng, and P. J. Chiao Function of Polo-like Kinase 3 in NF-{kappa}B-mediated Proapoptotic Response J. Biol. Chem., April 29, 2005; 280(17): 16843 - 16850. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |